CTLA4 and neoplasm: Experiments have shown that anti-CTLA-4 therapy combined with Treg consumption is more effective in inducing anti-tumor response than blocking CTLA-4 alone (150), reducing tumor Infiltrating Treg may be an important factor in determining immunotherapy response.